Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Cancer Research|February 1, 1979
Imidoester inhibition of lymphocyte DNA synthesisC A Presant, S ParkerCancer|October 1, 1977
Severe myelosuppression from piperazinedione, (NSC No. 135758), cyclophosphamide plus dimethyl-triazeno-imidazole carboxamide (DTIC)C A Presant, C KlahrMedical and Pediatric Oncology|January 1, 1983
Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovaryC A Presant, A BartolucciCancer|September 1, 1978
Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myelomaC A Presant, C KlahrThe Journal of Biological Chemistry|April 10, 1976
Surface alterations in calf lymphocytes oxidized by sodium periodateC A Presant, S ParkerClinical and Experimental Immunology|January 1, 1977
Enhanced DNA synthesis in isolated calf lymph node lymphocyte culturesC A Presant, S ParkerCancer|May 15, 1982
Prognostic factors in metastatic malignant melanoma: The Southeastern Cancer Study Group ExperienceC A Presant, A A BartolucciMedical and Pediatric Oncology|January 1, 1984
Phase II evaluation of chlorozotocin in metastatic sarcomasC A Presant, A A BartolucciThe Journal of Clinical Psychiatry|September 1, 1993
Tourette's syndrome and attention-deficit hyperactivity disorder: evidence for a genetic relationshipE R Knell, D E ComingsAmerican Journal of Clinical Oncology|April 1, 1982
Phase II trial of piperazinedione in metastatic sarcomaC A Presant, A A BartolucciPageof 7